Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.20.2
Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 4 $ 195,666 $ (186,857) $ 8,813
Balance, shares at Dec. 31, 2018 3,856,768      
Stock-based compensation 316 316
Stock-based compensation, shares 74      
Issuance of common stock from exercise of warrants 1,504 1,504
Issuance of common stock from exercise of warrants, shares 83,542      
Sale of common stock, net of offering costs 380 380
Sale of common stock, net of offering costs, shares 30,817      
Net loss     (5,670) (5,670)
Balance at Mar. 31, 2019 $ 4 197,866 (192,527) 5,343
Balance, shares at Mar. 31, 2019 3,971,201      
Stock-based compensation 277 277
Issuance of common stock from exercise of warrants
Issuance of common stock from exercise of warrants, shares 1,249      
Sale of common stock and warrants, net of offering costs $ 1 15,107 15,108
Sale of common stock and warrants, net of offering costs, shares 1,428,667      
Deemed dividend for warrant down-round protection provision 1 (1)
Net loss (5,027) (5,027)
Balance at Jun. 30, 2019 $ 5 213,251 (197,555) 15,701
Balance, shares at Jun. 30, 2019 5,401,117      
Balance at Dec. 31, 2019 $ 5 214,397 (208,758) 5,644
Balance, shares at Dec. 31, 2019 5,490,038      
Stock-based compensation 372 372
Sale of common stock, net of offering costs $ 1 2,673 2,674
Sale of common stock, net of offering costs, shares 337,944      
Net loss (5,670) (5,670)
Balance at Mar. 31, 2020 $ 6 217,442 (214,428) 3,020
Balance, shares at Mar. 31, 2020 5,827,982      
Stock-based compensation 210   210
Stock-based compensation, shares 5,240      
Issuance of common stock from exercise of pre-funded warrants $ 1 3 4
Issuance of common stock from exercise of pre-funded warrants, shares 1,200,000      
Sale of common stock and pre-funded warrants, net of offering costs $ 6 52,159 52,165
Sale of common stock and pre-funded warrants, net of offering costs, shares 6,138,602      
Deemed dividend for warrant down-round protection provision 1 (1)
Net loss (4,625) (4,625)
Balance at Jun. 30, 2020 $ 13 $ 269,815 $ (214,428) $ 50,774
Balance, shares at Jun. 30, 2020 13,171,824